Quarterly Call Option Transactions in Blueprint Medicines Corp (BPMC)
This table provides information about the institutional ownership of Blueprint Medicines Corp (BPMC) during . The information is specifically focused on institutions that hold call options of Blueprint Medicines Corp.
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 35,100 | 250,021 | 285,121 | 24,900 | 0 | 24,900 | 260,221 | |
| Q4 2021 | 1,500 | 25,000 | 26,500 | 12,300 | 310,100 | 322,400 | -295,900 | |
| Q1 2022 | 43,600 | 96,800 | 140,400 | 2,000 | 25,000 | 27,000 | 113,400 | |
| Q2 2022 | 54,900 | 70,000 | 124,900 | 0 | 25,000 | 25,000 | 99,900 | |
| Q3 2022 | 38,400 | 0 | 38,400 | 82,200 | 0 | 82,200 | -43,800 | |
| Q4 2022 | 0 | 43,100 | 43,100 | 139,100 | 0 | 139,100 | -96,000 | |
| Q1 2023 | 57,400 | 0 | 57,400 | 7,000 | 0 | 7,000 | 50,400 | |
| Q2 2023 | 0 | 51,400 | 51,400 | 35,400 | 0 | 35,400 | 16,000 | |
| Q3 2023 | 18,400 | 60,752 | 79,152 | 21,900 | 0 | 21,900 | 57,252 | |
| Q4 2023 | 152,745 | 544,600 | 697,345 | 49,000 | 0 | 49,000 | 648,345 | |
| Q1 2024 | 164,400 | 95,600 | 260,000 | 38,714 | 0 | 38,714 | 221,286 | |
| Q2 2024 | 349,300 | 79,500 | 428,800 | 9,600 | 0 | 9,600 | 419,200 | |
| Q3 2024 | 268,100 | 1,457,300 | 1,725,400 | 119,000 | 0 | 119,000 | 1,606,400 | |